News
03-31-2010, 10:52 PM
Omeros Corporation today announced that a Phase 2 clinical trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, demonstrated that patients treated with OMS103HP during arthroscopic knee meniscectomy surgery achieved statistically significant clinical benefits.
More... (http://www.news-medical.net/news/20100401/Positive-results-from-Phase-2-clinical-trial-of-OMS103HP.aspx)
More... (http://www.news-medical.net/news/20100401/Positive-results-from-Phase-2-clinical-trial-of-OMS103HP.aspx)